Taken together, our data show association of Apollon expression with chemotherapeutic response in ESCC, and provide a strong rationale for combining Apollon antagonism with chemotherapy to treat ESCC. The gene discussed is BIRC6; the disease is esophageal squamous cell carcinoma.